Outcomes of laparoscopic adrenalectomy for hyperaldosteronism
- PMID: 17685956
- DOI: 10.1111/j.1445-2197.2007.04225.x
Outcomes of laparoscopic adrenalectomy for hyperaldosteronism
Abstract
Background: Primary hyperaldosteronism is a frequent cause of resistant hypertension and is amenable to surgical intervention when caused by a unilateral aldosterone-producing adenoma. The aim of this study was to investigate the long-term results of laparoscopic adrenalectomy in the control of hypertension caused by primary hyperaldosteronism.
Methods: A prospective case series of patients undergoing laparoscopic adrenalectomy for hyperaldosteronism was studied. Blood pressure (BP), serum aldosterone levels, plasma renin activity, serum potassium and antihypertensive requirement were measured before and after adrenalectomy.
Results: Sixty-two patients with hyperaldosteronism underwent laparoscopic adrenalectomy in the period from December 1995 to August 2005. The median follow up was 59 months. There was a significant decrease in both systolic blood pressure and diastolic blood pressure at final follow up compared with that before operation. Systolic blood pressure decreased from 149 mmHg to 129 mmHg at final follow up (P < 0.0001). Diastolic blood pressure decreased from 89 mmHg to 80 mmHg (P < 0.0001). Antihypertensive requirement was decreased from an average of 2.6 separate medications preoperatively to 1.4 medications at final follow up (P < 0.0001). Serum aldosterone levels were significantly lower (698 (confidence interval 534-862) pg/mL vs 181 (confidence interval 139-225) pg/mL, P < 0.0001). Overall, 34% of patients had cure of hypertension and did not require any antihypertensive agent. A further 51% had improvement in BP control, whereas 5% had no change or had worsening hypertension. Multivariate regression analysis showed that age and gland size were independent factors predicting sustained hypertension after surgery.
Conclusion: In appropriately selected patients with primary hyperaldosteronism, laparoscopic adrenalectomy is effective in improving long-term BP control. Larger adrenal gland size and older age at time of surgery are predictors of persisting hypertension.
Similar articles
-
Surgical outcomes following laparoscopic adrenalectomy for treatment of Conn's syndrome (primary hyperaldosteronism) between 1999 and 2006.N Z Med J. 2010 Oct 15;123(1324):50-6. N Z Med J. 2010. PMID: 20953222
-
Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma.J Hypertens. 2008 Sep;26(9):1816-23. doi: 10.1097/HJH.0b013e3283060f0c. J Hypertens. 2008. PMID: 18698217
-
Clinical outcomes of laparoscopic adrenalectomy for lateralizing nodular hyperplasia.Surgery. 2005 Dec;138(6):1009-16; discussion 1016-7. doi: 10.1016/j.surg.2005.09.027. Surgery. 2005. PMID: 16360385
-
Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.Endocr Relat Cancer. 2008 Sep;15(3):693-700. doi: 10.1677/ERC-08-0094. Epub 2008 Jun 27. Endocr Relat Cancer. 2008. PMID: 18586836 Review.
-
Primary aldosteronism caused by aldosterone-producing adenoma in pregnancy--complicated by EPH gestosis.Wien Klin Wochenschr. 1999 Oct 29;111(20):855-7. Wien Klin Wochenschr. 1999. PMID: 10586491 Review.
Cited by
-
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling.Endocr Rev. 2025 Jul 15;46(4):501-517. doi: 10.1210/endrev/bnaf007. Endocr Rev. 2025. PMID: 39965116 Free PMC article. Review.
-
Cardiovascular changes in patients with primary aldosteronism after surgical or medical treatment.J Endocrinol Invest. 2012 Mar;35(3):274-80. doi: 10.3275/7611. Epub 2011 Mar 21. J Endocrinol Invest. 2012. PMID: 21422805
-
Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism.Ann Surg Oncol. 2013 Mar;20(3):753-8. doi: 10.1245/s10434-012-2670-2. Epub 2012 Oct 23. Ann Surg Oncol. 2013. PMID: 23090573 Free PMC article.
-
Laparoscopic adrenalectomy performed by a general surgeon on functioning adrenal tumors: Treatment outcomes and risk prediction of persistent hypertension.Qatar Med J. 2024 Aug 8;2024(3):30. doi: 10.5339/qmj.2024.30. eCollection 2024. Qatar Med J. 2024. PMID: 39156635 Free PMC article.
-
Predictors of malignancy in primary aldosteronism.Langenbecks Arch Surg. 2014 Jan;399(1):93-8. doi: 10.1007/s00423-013-1121-2. Epub 2013 Sep 19. Langenbecks Arch Surg. 2014. PMID: 24048685
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources